1. Purves, D. Neuroscience 4th ed. Sunderland, Mass. : Sinauer: 2008.
2. Takuma, K.; Baba, A.; Matsuda, T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 2004, 72, 111-27.
3. Bèahr, M. Neuroprotection : models, mechanisms, and therapies Wiley-VCH:
2004.
4. Tanaka, K.; Watase, K.; Manabe, T.; Yamada, K.; Watanabe, M.; Takahashi, K.;
Iwama, H.; Nishikawa, T.; Ichihara, N.; Kikuchi, T.; Okuyama, S.; Kawashima, N.;
Hori, S.; Takimoto, M.; Wada, K. Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1. Science 1997, 276, 1699-1702.
5. Smith, G. M.; Rutishauser, U.; Silver, J.; Miller, R. H. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Developmental Biology 1990, 138, 377-390.
6. Tiveron, M.-C.; Barboni, E.; Pliego Rivero, F. B.; Gormley, A. M.; Seeley, P. J.;
Grosveld, F.; Morris, R. Selective inhibition of neurite outgrowth on mature astrocytes by Thy-1 glycoprotein. Nature 1992, 355, 745-748.
7. Burkhard Becher, A. P. J. P. A. Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia 2000, 29, 293-304.
8. de Bernardo, S.; Canals, S.; Casarejos, M. J.; Solano, R. M.; Menendez, J.; Mena, M. A. Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures. Journal of Neurochemistry 2004, 91, 667-682.
9. Fiona E. Parkinson, J. F. C. R. Z. W. X. Gene expression for enzymes and transporters involved in regulating adenosine and inosine levels in rat forebrain neurons, astrocytes and C6 glioma cells. Journal of Neuroscience Research 2006, 84, 801-808.
10. Bohme, H.; Schmidt, W. Oxo compounds of the benzothiazine series. Arch.
Pharm. 1953, 286, 437-41.
11. Sheu, S.-Y.; Lin, C.-Y.; Wu, J.-D.; Chiang, H.-C. Inhibition of xanthine oxidase by benzothiazinone analogs. Anticancer Research 1999, 19, 119-123.
12. Perkins, E.; Sun, D.; Nguyen, A.; Tulac, S.; Francesco, M.; Tavana, H.; Nguyen, H.; Tugendreich, S.; Barthmaier, P.; Couto, J.; Yeh, E.; Thode, S.; Jarnagin, K.; Jain, A.; Morgans, D.; Melese, T. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Research 2001, 61, 4175-4183.
13. Melese, T.; Perkins, E. L.; Yeh, E.; Sun, D. Heterocyclic poly(ADP-ribose)
polymerase (PARP) inhibitors. 2001-US46811 2002044157, 20011203., 2002.
14. Kajino, M.; Kawada, A.; Nakayama, Y.; Kimura, H. Preparation of 2-heterocyclyl-1,3-benzothiazinone derivatives as inhibitors of apoptosis or cytoprotective agents. 2002-JP8866
2003020719, 20020902., 2003.
15. Kajino, M.; Nakayama, Y.; Kimura, A. Preparation of 1,3-benzothiazinones as macrophage migration inhibitory factor binders and apoptosis inhibitors, and treatment of diseases with them or their prodrugs. 2003-406172
2004196792, 20031204., 2004.
16. Kimura, H.; Sato, Y.; Takizawa, M.; Horiguchi, T.; Notoya, K. Cell death inhibitor. 2003-JP5256
2003090782, 20030424., 2003.
17. Kimura, H.; Tanida, S.; Kaneko, T. Preparation of benzothiazinone derivatives as heart muscular cell apoptosis inhibitors and remedies for heart diseases. 2001-JP7468 2002018356, 20010830., 2002.
18. Kajino, M.; Imaeda, T. Preparation of 1,3-benzothiazinone derivatives having a capability of binding to a macrophage migration inhibitory factor (MIF) and
activating of an antioxidant response element (ARE). 2006-JP311977 2006132438, 20060608., 2006.
19. Gilkerson, T.; Jennens, D. C.; Coombs, M. E. Preparation of benzothiazinone derivatives as agrochemical fungicide. 87-200819
245902, 19870429., 1987.
20. Wolf, M.; Sellstedt, J. H. Analgesic 2-substituted-4H-1,3-benzothiazin-4-ones.
67-627296
3470168, 19670331., 1969.
21. Gheorghiu, C. V.; Stoicescu-Crivetz, L.; Budeanu, C.; Budeanu, E.;
Alexa-Petrovanu, M.; Mandasescu, L.; Constantinescu, N.; Toma, A.; Stavri, G.
Antituberculous substances. Rev. chim., Acad. rep. populaire Roumaine 1956, 1, 97-125.
22. 李惠玲. Synthesis of 2-Amino-Benzo[e][1,3]thiazin-4-ones Derivatives and Studies of Their Central Nervous System Activities. Taipei Medical University, Taipei, 2002.
23. Posse de Chaves, E. I. Sphingolipids in apoptosis, survival and regeneration in the nervous system. Biochim Biophys Acta 2006, 1758, 1995-2015.
24. Pettus, B. J.; Chalfant, C. E.; Hannun, Y. A. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 2002, 1585, 114-125.
127
25. Lahiri, S.; Futerman, A. H. The metabolism and function of sphingolipids and glycosphingolipids. Cell Mol Life Sci 2007, 64, 2270-84.
26. Muller, G.; Ayoub, M.; Storz, P.; Rennecke, J.; Fabbro, D.; Pfizenmaier, K. PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO Journal 1995, 14, 1961-1969.
27. Lozano, J.; Berra, E.; Municio, M. M.; Diaz-Meco, M. T.; Dominguez, I.; Sanz, L.; Moscat, J. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 1994, 269, 19200-19202.
28. Heinrich, M.; Wickel, M.; Winoto-Morbach, S.; Schneider-Brachert, W.; Weber, T.; Brunner, J.; Saftig, P.; Peters, C.; Kro?nke, M.; Schu?tze, S. Ceramide as an activator lipid of cathepsin D. In Advances in Experimental Medicine and Biology, 2000; Vol. 477, pp 305-315.
29. Wolff, R. A.; Dobrowsky, R. T.; Bielawska, A.; Obeid, L. M.; Hannun, Y. A. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction.
J. Biol. Chem. 1994, 269, 19605-19609.
30. Dobrowsky, R. T.; Kamibayashi, C.; Mumby, M. C.; Hannun, Y. A. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 1993, 268,
15523-15530.
31. Dobrowsky, R. T.; Hannun, Y. A. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 1992, 267, 5048-5051.
32. Bourbon, N. A.; Yun, J.; Kester, M. Ceramide directly activates protein kinase C z to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 2000, 275, 35617-35623.
33. Muller, G.; Ayoub, M.; Storz, P.; Renneck, J.; Fabbro, D.; Pfizenmaier, K. PKC z is a molecular switch in signal transduction of TNF-alpha , bifunctionally regulated by ceramide and arachidonic acid. Embo J. 1995, 14, 1961-9.
34. Ruvolo, P. P. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol. Res. 2003, 47, 383-392.
35. Zhang, Y.; Yao, B.; Delikat, S.; Bayoumy, S.; Lin, X.-H.; Basu, S.; McGinley, M.;
Chan-Hui, P.-Y.; Lichenstein, H.; Kolesnick, R. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell (Cambridge, Mass.) 1997, 89, 63-72.
36. Gulbins, E.; Grassme, H. Ceramide and cell death receptor clustering. Biochim.
Biophys. Acta, Mol. Cell Biol. Lipids 2002, 1585, 139-145.
37. Huwiler, A.; Johansen, B.; Skarstad, A.; Pfeilschifter, J. Ceramide binds to the CaLB domain of cytosolic phospholipase A2 and facilitates its membrane docking and arachidonic acid release. Faseb J. 2001, 15, 7-9.
38. Westwick, J. K.; Bielawska, A. E.; Dbaibo, G.; Hannun, Y. A.; Brenner, D. A.
Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 1995, 270,
2689-92.
39. Blazquez, C.; Galve-Roperh, I.; Guzman, M. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase. Faseb J. 2000, 14, 2315-2322.
40. Yao, B.; Zhang, Y.; Delikat, S.; Mathias, S.; Basu, S.; Kolesnick, R.
Phosphorylation of Raf by ceramide-activated protein kinase. Nature (London) 1995, 378, 307-10.
41. Gulbins, E.; Bissonnette, R.; Mahboubi, A.; Martin, S.; Nishioka, W.; Brunner, T.;
Baier, G.; Baier-Bitterlich, G.; Byrd, C.; et al. Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 1995, 2, 341-51.
42. Brenner, B.; Koppenhoefer, U.; Weinstock, C.; Linderkamp, O.; Lang, F.;
Gulbins, E. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 1997, 272, 22173-22181.
43. Embade, N.; Valeron, P. F.; Aznar, S.; Lopez-Collazo, E.; Lacal, J. C. Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production.
Mol. Biol. Cell 2000, 11, 4347-4358.
44. Gruber, C.; Henkel, M.; Budach, W.; Belka, C.; Jendrossek, V. Involvement of tyrosine kinase p56/Lck in apoptosis induction by anticancer drugs. Biochem.
Pharmacol. 2004, 67, 1859-1872.
45. Gulbins, E.; Szabo, I.; Baltzer, K.; Lang, F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc.
Natl. Acad. Sci. U. S. A. 1997, 94, 7661-7666.
46. Bollinger Claudia, R.; Teichgraber, V.; Gulbins, E. Ceramide-enriched membrane domains. Biochim Biophys Acta 2005, 1746, 284-94.
47. Gulbins, E.; Kolesnick, R. Raft ceramide in molecular medicine. Oncogene 2003, 22, 7070-7077.
48. Brown, D. A.; London, E. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 1998, 164, 103-114.
49. Siskind, L. J.; Kolesnick, R. N.; Colombini, M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations.
Mitochondrion 2006, 6, 118-125.
50. Siskind, L. J.; Kolesnick, R. N.; Colombini, M. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J. Biol. Chem.
2002, 277, 26796-26803.
51. Gudz, T. I.; Tserng, K.-Y.; Hoppel, C. L. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J. Biol. Chem. 1997, 272, 24154-24158.
129
52. Garcia-Ruiz, C.; Morales, A.; Colell, A.; Rodes, J.; Yi, J.-R.; Kaplowitz, N.;
Fernandez-Checa, J. C. Evidence that the rat hepatic mitochondrial carrier is distinct from the sinusoidal and canalicular transporters for reduced glutathione. Expression studies in Xenopus laevis oocytes. J. Biol. Chem. 1995, 270, 15946-9.
53. Yang, D.-I.; Yeh, C.-H.; Chen, S.; Xu, J.; Hsu, C. Y. Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide.
Neurobiol. Dis. 2004, 17, 99-107.
54. Yoshimura, S.-I.; Banno, Y.; Nakashima, S.; Hayashi, K.; Yamakawa, H.;
Sawada, M.; Sakai, N.; Nozawa, Y. Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. J. Neurochem.
1999, 73, 675-683.
55. Wang, C. X.; Brindley, D. N.; Shuaib, A. Role of ceramide in ischemic brain injury in an embolic model of stroke in rats. Int. J. Angiol. 2006, 15, 165-170.
56. Mathias, S.; Pena, L. A.; Kolesnick, R. N. Signal transduction of stress via ceramide. Biochem. J. 1998, 335, 465-480.
57. Schenck, M.; Carpinteiro, A.; Grassme, H.; Lang, F.; Gulbins, E. Ceramide:
Physiological and pathophysiological aspects. Arch. Biochem. Biophys. 2007, 462, 171-175.
58. Brugg, B.; Michel, P. P.; Agid, Y.; Ruberg, M. Ceramide Induces Apoptosis in Cultured Mesencephalic Neurons. Journal of Neurochemistry 1996, 66, 733-739.
59. Mosmann, T. Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65, 55-63.
60. Wilson, A. P. Cytotoxicity and viability assays. Anim. Cell Cult. (3rd Ed.) 2000, 175-219.
61. Chen, Y.-C.; Chow, J.-M.; Lin, C.-W.; Wu, C.-Y.; Shen, S.-C. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol. Appl.
Pharmacol. 2006, 216, 263-273.
62. Liu, K. C.; Shih, B. J. An efficient synthesis of 2-hydrazono-3,4
dihydro-2H-1,3-benzothiazin-4-one. Chung-hua Yao Hsueh Tsa Chih 1988, 40, 245-51.
63. Liu, K. C.; Shih, B. J.; Chern, J. W. Condensed 1,3-benzothiazinones. 3.
Synthesis of 3-substituted 1,2,4-triazolo[3,4-b][1,3]benzothiazin-5-ones. J. Heterocycl.
Chem. 1990, 27, 391-5.
64. Brown, D. J.; Nagamatsu, T. Isomerizations akin to the Dimroth rearrangement.
III. The conversion of simple s-triazolo[4,3-a]pyrimidines into their [1,5-a] isomers.
Australian Journal of Chemistry 1977, 30, 2515-25.
65. Alvarez, S. G.; Alvarez, M. T. A practical procedure for the synthesis of alkyl azides at ambient temperature in dimethyl sulfoxide in high purity and yield.
Synthesis 1997, 413-414.
66. Sheehan, J. C.; Bolhofer, W. A. An improved procedure for the condensation of potassium phthalimide with organic halides. Journal of the American Chemical Society 1950, 72, 2786-8.
67. Urquhart, G. G.; Gates, J. W., Jr.; Connor, R. Dodecyl (lauryl) mercaptan. Org.
Synth. 1941, 21, 36-8.
68. Saito, Y.; Wada, N.; Kusano, S.; Miyazawa, T.; Takahashi, S.; Toyokawa, Y.;
Kajiwara, I. Preparation and formulation of
2-[(carboxyphenyl)thio]-4,6-dimethoxypyrimidines as herbicides. 89-415871 4932999, 19891002., 1990.
69. Robert M. Silverstein, F. X. W., David J. Kiemle. Spectrometric identification of organic compounds. John Wiley & Sons: 2005.
70. Khlifi, M.; Paillous, P.; Bruston, P.; Raulin, F.; Guillemin, J. C. Absolute IR Band Intensities of CH2N2, CH3N3, and CH3NC in the 250-4300 cm-1Region and Upper Limits of Abundance in Titan's Stratosphere. Icarus 1996, 124, 318-328.
71. Wagner, G.; Richter, P. Preparation and Dimroth rearrangement of 2-imino-4-oxodihydro-5,6-benzo-1,3-thiazines. Z. Chem. 1967, 7, 231.
72. Wagner, G.; Richter, P. Synthesis and reaction of 2-imino-4-oxo- and 2-oxo-4-iminodihydro-2H-1,3-benzothiazines. Pharmazie 1969, 24, 100-8.
73. Ceraulo, L.; Agozzino, P.; Ferrugia, M.; Giannola, L. I. Studies in organic mass spectrometry. I. Electron impact-induced fragmentation of 2-substituted
4H-1,3-benzothiazin-4-ones. Ann. Chim. (Rome) 1977, 67, 707-19.
74. Liu, K. C.; Shih, B. J.; Chern, J. W. Condensed 1,3-benzothiazinones. 2.
Synthesis of 2-substituted 1,2,4-triazolo[5,1-b][1,3]benzothiazin-9-ones. J. Heterocycl.
Chem. 1989, 26, 457-60.